Works matching IS 09291903 AND DT 2000 AND VI 7 AND IP 4

Results: 18

Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 526

By:

Álvarez-Vallina, Luis;
Yañez, Rosa;
Blanco, Belén;
Gil, Magdalena;
Russell, Stephen J

Publication type:

Article

Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 557, doi. 10.1038/sj.cgt.7700134

By:

Hasegawa, Yoshinori;
Nishiyama, Yukihiro;
Imaizumi, Kazuyoshi;
Ono, Nobukazu;
Kinoshita, Tomohiro;
Hatano, Sonoko;
Saito, Hidehiko;
Shimokata, Kaoru

Publication type:

Article

Efficient cotransduction of tumors by multiple herpes simplex vectors: Implications for tumor vaccine production.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 581, doi. 10.1038/sj.cgt.7700135

By:

Karpoff, Howard M;
Kooby, David;
D’Angelica, Michael;
Mack, Jonathan;
Presky, David H;
Brownlee, Michael D;
Federoff, Howard;
Fong, Yuman

Publication type:

Article

Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 574, doi. 10.1038/sj.cgt.7700153

By:

Candotti, Fabio;
Agbaria, Riad;
Mullen, Craig A;
Touraine, Renaud;
Balzarini, Jan;
Johns, David G;
Blaese, R Michael

Publication type:

Article

Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 629, doi. 10.1038/sj.cgt.7700139

By:

Kammertoens, Thomas;
Gelbmann, Wolfgang;
Karle, Peter;
Alton, Klemens;
Saller, Robert;
Salmons, Brian;
Günzburg, Walter H;
Uckert, Wolfgang

Publication type:

Article

Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 637, doi. 10.1038/sj.cgt.7700154

By:

Kawamura, Kiyoko;
Tasaki, Kentaro;
Hamada, Hirofumi;
Takenaga, Keizo;
Sakiyama, Shigeru;
Tagawa, Masastoshi

Publication type:

Article

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 537, doi. 10.1038/sj.cgt.7700148

By:

Horio, Yoshitsugu;
Hasegawa, Yoshinori;
Sekido, Yoshitaka;
Takahashi, Masahide;
Roth, Jack A;
Shimokata, Kaoru

Publication type:

Article

Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 545, doi. 10.1038/sj.cgt.7700150

By:

Cascalló, Manel;
Calbó, Joaquim;
Gelpí, Josef Lluís;
Mazo, Adela

Publication type:

Article

Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53).

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 530, doi. 10.1038/sj.cgt.7700138

By:

Yen, Nancy;
Ioannides, Constantin G;
Xu, Kai;
Swisher, Stephen G;
Lawrence, David D;
Kemp, Bonnie L;
El-Naggar, Adel K;
Cristiano, Richard J;
Fang, Bingliang;
Glisson, Bonnie S;
Hong, Waun K;
Khuri, Fadlo R;
Kurie, Jonathan M;
Lee, J Jack;
Lee, Jin S;
Merritt, James A;
Mukhopadhyay, Tapas;
Nesbitt, Jonathan C;
Nguyen, Dao;
Perez-Soler, Roman

Publication type:

Article

Frape-1 and Frape-3: Two different recombinant retroviruses encoding the same human marker gene.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 624, doi. 10.1038/sj.cgt.7700157

By:

Ng, Yuk-Yin;
Veenhuizen, Peter;
Lokhorst, Henk;
Staal, Frank J T

Publication type:

Article

A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin from endogenous plasminogen by protease gene transfer.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 589, doi. 10.1038/sj.cgt.7700147

By:

Matsuda, Kant M;
Madoiwa, Seiji;
Hasumi, Yoko;
Kanazawa, Takeharu;
Saga, Yasushi;
Kume, Akihiro;
Mano, Hiroyuki;
Ozawa, Keiya;
Matsuda, Michio

Publication type:

Article

Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cells.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 597, doi. 10.1038/sj.cgt.7700159

By:

Veldwijk, Marlon R;
Fruehauf, Stefan;
Schiedlmeier, Bernhard;
Kleinschmidt, Juergen A;
Zeller, W Jens

Publication type:

Article

Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivatives.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 644, doi. 10.1038/sj.cgt.7700170

By:

Poulain, Laurent;
Ziller, Christelle;
Muller, Christian D;
Erbacher, Patrick;
Bettinger, Thierry;
Rodier, Jean-François;
Behr, Jean-Paul

Publication type:

Article

A new cholesterol derivative suitable for transfecting certain type of cells in the presence of 10% serum.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 513, doi. 10.1038/sj.cgt.7700167

By:

Sochanik, Aleksander;
Kaida, Irina;
Mitrus, Iwona;
Rajca, Andrzej;
Szala, Stanisław

Publication type:

Article

Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 615, doi. 10.1038/sj.cgt.7700161

By:

Paul, Stéphane;
Bizouarne, Nadine;
Dott, Karine;
Ruet, Ludovic;
Dufour, Patrick;
Acres, R Bruce;
Paule Kieny, Marie

Publication type:

Article

The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapy.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 521, doi. 10.1038/sj.cgt.7700165

By:

Thatcher, Natalie J;
Edwards, Robert J;
Lemoine, Nicholas R;
Doehmer, Johannes;
Davies, Donald S

Publication type:

Article

Two-drug combinations that increase apoptosis and modulate Bak and Bcl-XL expression in human colon tumor cell lines transduced with herpes simplex virus thymidine kinase.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 563, doi. 10.1038/sj.cgt.7700164

By:

McMasters, Robyn A;
Wilbert, Tasha N;
Jones, Kelly E;
Pitlyk, Karen;
Saylors, Robert L;
Moyer, Mary Pat;
Chambers, Timothy C;
Drake, Richard R

Publication type:

Article

CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy.

Published in:

Cancer Gene Therapy, 2000, v. 7, n. 4, p. 605, doi. 10.1038/sj.cgt.7700187

By:

Lohmann, Sabine;
Galle, Katharina;
Knop, Jürgen;
Enk, Alexander H

Publication type:

Article

Works matching IS 09291903 AND DT 2000 AND VI 7 AND IP 4

Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptors.

Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.

Efficient cotransduction of tumors by multiple herpes simplex vectors: Implications for tumor vaccine production.

Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.

Combined chemotherapy of murine mammary tumors by local activation of the prodrugs ifosfamide and 5-fluorocytosine.

Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.

Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of non-small cell lung cancer cells.

Modulation of drug cytotoxicity by reintroduction of wild-type p53 gene (Ad5CMV-p53) in human pancreatic cancer.

Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53).

Frape-1 and Frape-3: Two different recombinant retroviruses encoding the same human marker gene.

A novel strategy for the tumor angiogenesis-targeted gene therapy: Generation of angiostatin from endogenous plasminogen by protease gene transfer.

Differential expression of a recombinant adeno-associated virus 2 vector in human CD34<sup>+</sup> cells and breast cancer cells.

Ovarian carcinoma cells are effectively transfected by polyethylenimine (PEI) derivatives.

A new cholesterol derivative suitable for transfecting certain type of cells in the presence of 10% serum.

Redirected cellular cytotoxicity by infection of effector cells with a recombinant vaccinia virus encoding a tumor-specific monoclonal antibody.

The potential of acetaminophen as a prodrug in gene-directed enzyme prodrug therapy.

Two-drug combinations that increase apoptosis and modulate Bak and Bcl-X<sub>L</sub> expression in human colon tumor cell lines transduced with herpes simplex virus thymidine kinase.

CD83<sup>+</sup> human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: A potential tool for gene immunotherapy.